We have examined the microstructure, solution processing, thermal transitions, and
mechanical properties of regioregular poly(nonylbithiazole) (PNBT). PNBT can adopt three distinct colors
in the solid stateyellow, red, and metallic greendepending on processing conditions such as polymer
concentration, solvent evaporation rate, temperature, and pressure. Microstructural variations were
observed between samples of different colors, including the intensification of optical absorption with the
degree of crystalline order and/or crystal size. Yellow samples lacked well-developed three-dimensional
order, whereas red and green samples were semicrystalline. The development of a lyotropic mesophase
was observed at intermediate concentrations in a “diffusion couple” geometry. A crystal model with two
planar, π-stacked chains per unit cell was shown to be consistent with the experimental diffraction data.
The simulated orthorhombic unit cell parameters are a = 2.38 nm, b = 0.72 nm, and c = 0.79 nm.
The synthesis of poly(4,4′-dinonyl-2,2′-bisoxazole-5,5′-diyl) (PNBO) was performed through a nickel-mediated coupling of 5,5′-dibromo-4,4′-dinonyl-2,2′-bisoxazole. The solid-state morphology of PNBO was determined by powder X-ray diffraction (XRD) which showed strong peaks due to lamellar spacing and three-dimensional ordering. The polymer has absorbance maxima of 446 and 464 nm in solution, and 475 nm in the film. A low wavelength shoulder near 510 nm is ascribed to the absorption of aggregated molecules. The emission spectra are concentration dependent and consistent with emission from excimers. Essentially all the emission in the solid state is due to excimers. The physical and chemical properties of PNBO are compared to the sulfur analogues, poly(4,4′-dinonyl-2,2′-bithiazole-5,5′-diyl) (PNBTz) and poly(3-alkylthiophene)s.
The ∼2.4 nm (100) lattice planes of electrooptically active poly(nonylbithiazole) (PNBT)
and poly(nonylbisoxazole) (PNBO) crystallites have been imaged by means of low-dose high-resolution
transmission electron microscopy (HRTEM). The average dimensions of the observed crystallites were
(14 ± 9) × (13 ± 6) nm (width vs length) and (80 ± 36) × (22 ± 9) nm for PNBT and PNBO, respectively.
Atomization of dilute polymer solutions led to the formation of discontinuous thin films containing
numerous holes. The influence of these surfaces on the crystallization process was evident in the
preferential parallel orientation of the (100) fringes with respect to the film edges. Evidence of considerable
lattice bending about the [010] (π−π stacking) direction was observed in both compounds. Two-dimensional
maps of the local lattice curvature revealed substantial differences in the modes of deformation of the
two polymers: PNBT crystallites curved in a continuous fashion, whereas PNBO crystallites localized
the distortions. Possible factors that could influence the observed deformation mechanisms are discussed.
Regioregular, alkyl-substituted poly(heteroaromatics) tend to crystallize in π-stacked structures as opposed to the herringbone pattern characteristic of non-substituted, planar aromatic molecules, e.g. sexithiophene. π-Stacking, favored by the crystallization of the sidechains, induces planarity in the conjugated backbone. The increased planarity causes a large (50-100 nm) shift in λmax (abs.) compared to the solution phase in which the backbone is twisted out of coplanarity, π-Stacking is a form of ground state aggregation that causes “fine structure” on the absorption peak. Excitation into the aggregate states rapidly leads to the formation of excimers as shown by the excitation spectra. In -stacked polymers, photoluminescence is almost entirely from the excimer states.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.